Koninklijke Philips | PHG - Sales Revenues


Koninklijke Philips reported EUR5.93B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Baxter International USD 2.97B 130M Dec/2025
Becton, Dickinson and Co. USD 5.3B 600M Dec/2025
Boston Scientific USD 5.2B 90M Mar/2026
Danaher USD 5.95B 890M Mar/2026
Demant DKK 6.26B 810M Dec/2025
Dexcom USD 1.26B 50M Dec/2025
Edwards Lifesciences USD 1.65B 80M Mar/2026
Fresenius EUR 5.88B 400M Dec/2025
General Electric Aerospace USD 11.6B 270M Mar/2026
Getinge SEK 11.07B 3.2B Dec/2024
Globus Medical USD 826.4M 57.4M Dec/2025
GN Store Nord DKK 4.68B 720M Dec/2025
Hitachi JPY 3.08T 370B Mar/2026
Idexx Laboratories USD 1.09B 10M Dec/2025
Insulet USD 783.8M 77.5M Dec/2025
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
J&J USD 24.1B 500M Mar/2026
Koninklijke Philips EUR 5.93B 905.95M Dec/2025
Masimo USD 412.5M 41M Dec/2025
Medtronic USD 9B 39M Jan/2026
Philips EUR 5.1B 797M Dec/2025
ResMed USD 1.4B 100M Dec/2025
Smith & Nephew USD 3.18B 353M Dec/2025
Steris USD 1.5B 470M Dec/2025
Stryker USD 7.2B 1.14B Dec/2025
Teleflex USD 568.98M 344.02M Dec/2025
Terumo JPY 296.63B 21.66B Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026